IFP Advisors’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-490
Closed -$1K 4687
2021
Q4
$1K Hold
490
﹤0.01% 3218
2021
Q3
$1K Hold
490
﹤0.01% 3241
2021
Q2
$0 Hold
490
﹤0.01% 3377
2021
Q1
$0 Hold
490
﹤0.01% 3375
2020
Q4
$0 Hold
490
﹤0.01% 3249
2020
Q3
$0 Hold
490
﹤0.01% 3143
2020
Q2
$0 Hold
490
﹤0.01% 3111
2020
Q1
$0 Hold
490
﹤0.01% 3181
2019
Q4
$0 Hold
490
﹤0.01% 3347
2019
Q3
$0 Buy
+490
New +$435 ﹤0.01% 3228

IFP Advisors's SPHS Position: Q1 2022 in Review

IFP Advisors sold out of Sophiris Bio, Inc. (SPHS) in Q1 2022, closing a stake of 490 shares — an estimated $1K sold.

IFP Advisors first reported a position in SPHS in Q3 2019 and held it in 10 quarters. The position peaked at $1K in Q4 2021. 0 funds tracked by Wall St. Rank hold SPHS as of Q1 2022.

  • IFP Advisors reported no remaining Sophiris Bio, Inc. position as of Q1 2022 after selling out during the quarter.
  • IFP Advisors sold 490 Sophiris Bio, Inc. shares in Q1 2022, an estimated $1K.
  • IFP Advisors first reported a position in Sophiris Bio, Inc. in Q3 2019 and held it in 10 quarters.
  • IFP Advisors's Sophiris Bio, Inc. position peaked at $1K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2022.

Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.